Literature DB >> 19869912

BLOOD CHEMICAL CHANGES IN EXPERIMENTAL STREPTOCOCCUS SEPTICEMIA.

R W Linton1.   

Abstract

The following changes have been found to occur in rabbits given fatal intravenous doses of Streptococcus hemolyticus: The blood sugar concentration drops at a constant rate throughout the disease, but does not reach a condition of hypoglycemia. Glycogen is present in the liver at death. The CO(2) capacity is lowered markedly at first, then returns to a somewhat higher level, at which it continues until the terminal stage of the disease, when the acidosis becomes very marked. Inorganic phosphorus is markedly increased in concentration at the terminus of the disease. This increase is greater in animals showing an acute course than in those in which the disease is of the fulminating type. Calcium also shows terminal changes, decreases occurring in both groups. In the acutely infected rabbits the decrease is less than in the fulminating group, although in both a pathological level is reached. Non-protein nitrogen and creatinine are greatly increased in the terminal stages, in both groups of animals. It is suggested that these observations can be explained on the assumption of a large amount of acid production by the streptococcus in vivo.

Entities:  

Year:  1931        PMID: 19869912      PMCID: PMC2131953          DOI: 10.1084/jem.54.2.223

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  BIOMETRY OF CALCIUM, INORGANIC PHOSPHORUS, CHOLESTEROL, AND LIPOID PHOSPHORUS IN THE BLOOD OF RABBITS : I. NORMAL ANIMALS FROM RECENTLY ACQUIRED STOCK.

Authors:  A R Harnes
Journal:  J Exp Med       Date:  1928-09-30       Impact factor: 14.307

2.  THE EFFECT OF INJECTIONS OF HEMOLYTIC STREPTOCOCCI ON SUSCEPTIBLE AND INSUSCEPTIBLE ANIMALS.

Authors:  J G Hopkins; J T Parker
Journal:  J Exp Med       Date:  1918-01-01       Impact factor: 14.307

3.  THE BLOOD CHEMISTRY OF AN ACUTE TRYPANOSOME INFECTION.

Authors:  R W Linton
Journal:  J Exp Med       Date:  1930-06-30       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.